Response to: Letter to the Editor from Fitzpatrick et al: Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion? / G. Grassi, A. Ghielmetti, M. Zampogna, I. Chiodini, M. Arosio, G. Mantovani, C. Eller-Vainicher. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2024), pp. 1-2. [Epub ahead of print] [10.1210/clinem/dgae493]
Response to: Letter to the Editor from Fitzpatrick et al: Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?
G. GrassiPrimo
;A. GhielmettiSecondo
;M. Zampogna;I. Chiodini;M. Arosio;G. MantovaniPenultimo
;C. Eller-VainicherUltimo
2024
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
194 - Response to Zol after Dmab discontinuation - JCEM 2024.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
164.01 kB
Formato
Adobe PDF
|
164.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
